Somatin 1.3mg 4ME (pharmacy)

Growth hormone pharmacy, high quality, there are documents and certificates.

PHARMACOLOGICAL PROPERTIES:

Recombinant human growth hormone. It is a peptide of 191 amino acids, identical to human pituitary growth hormone in amino acid sequence and composition, as well as in peptide map, isoelectric point, molecular mass, isomeric structure and biological activity.
It has anabolic and anti-catabolic effects, affects metabolism, growth and development of the body. It interacts with specific receptors of cells of different types, including myocytes, hepatocytes, adipocytes, lymphocytes and hematopoietic cells. Some ego effects are mediated by the second class of hormones — somatomedins (IGF1  and IGF2).
Depending on the dose, somatropin causes an increase in the level of IGF1, IGFBP3, non-esterified fatty acids and glycerol, a decrease in the level of urea in the blood and nitrogen in the urine, and a decrease in the excretion of sodium and potassium. When used in high doses, relative saturation of the effects of somatropin is possible. This does not apply to glycemia and urinary excretion of C-peptide, which significantly increase only after high doses (20 mg). In higher doses (60 IU, or 20 mg), it is impossible to exclude some degree of nonlinearity, which, however, does not have clinical significance. After intravenous administration to healthy volunteers, the volume of distribution in the steady state is almost 7 l, the total clearance — 15 l/h, while renal clearance is insignificant. T½— 20–35 min.
After a single p/c and i/m introduction terminal T½ neskołko bolshe — 2– 4 h. The concentration of growth hormone in the blood reaches a maximum after approximately 4 hours and returns to the initial level within 24 hours, which indicates the absence of accumulation of growth hormone during repeated administrations. Bioavailability with both routes of administration is 70–90%.